10.5061/DRYAD.QG87N
Canavan, Caroline
University of Nottingham
West, Joe
University of Nottingham
Card, Timothy
University of Nottingham
Data from: Change in quality of life for patients with Irritable Bowel
Syndrome following referral to a gastroenterologist: a cohort study
Dryad
dataset
2016
Irritable bowel syndrome
utility
Quality of life
2016-09-16T00:00:00Z
2016-09-16T00:00:00Z
en
https://doi.org/10.1371/journal.pone.0139389
13747 bytes
1
CC0 1.0 Universal (CC0 1.0) Public Domain Dedication
Background: Irritable bowel syndrome (IBS), a chronic functional
condition, considerably reduces quality of life (QoL) and referral to
gastroenterology is common. Until now, however, the impact of seeing a
gastroenterologist for IBS on patients’ QoL and utility has not been
assessed. Methods: Patients referred with “probable IBS” to the Nottingham
Treatment Centre between October 2012 and March 2014 were invited to
complete a QoL questionnaire (EuroQol–5 Dimension) before their first
appointment. Patients with confirmed IBS who completed this baseline
assessment were sent follow-up questionnaires three and twelve months
later. Global QoL and utility were measured at each time point and change
from baseline calculated. Paired t-tests analysed the significance of any
change. Results: Of 205 invited patients, 69 were eligible and recruited.
Response at three and twelve months was 45% and 17% respectively. Median
global QoL at baseline was 67.5 (Interquartile range [IQR] 50.0 to 80.0),
with a mean increase of 3.25 (95% confidence interval [CI] -5.38 to 11.88)
three months later and a mean decrease of -1.82 (95% CI -16.01 to 12.38)
after one year. The median utility at baseline was 0.76 (IQR 0.69 to
0.80), with a mean increase of 0.06 (95%CI -0.01 to 0.14) at three months
and no change, 0.00 (-0.16 to 0.16), after one year. Conclusion: Patients
experienced a small but not statistically significant increase in QoL and
utility three months after seeing a gastroenterologist for IBS, which was
not maintained. Gastroenterology referral does not appear to appreciably
improve Qol for most people with IBS.
anonymised responses of those recuitedEQ5D responses over three rounds.
Sex and age stratification data. All EQ5D scores in raw form to be entered
into state valuation algorythm
UK